Sunday, September 29, 2024
HomeTagsPhase 3 Protocol

Phase 3 Protocol

RegeneRx Partner Submits Phase 3 Protocol for Neurotrophic Keratopathy (NK)

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting that its U.S. joint venture (JV) partner...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics